【Abstract】Objective Hyperkalemia is a common complication in patients with end stage renal disease due to impaired renal potassium excretion. Higher pre-dialysis serum potassium may cause heart rhythm disturbances and even fatal cardiac arrest. This study assessed the prevalence of hyperkalemia in hemodialysis (HD) patients based on the China Dialysis Outcomes and Practice Patterns Study (DOPPS), and explored the independent risk factors of hyperkalemia in HD patients. Methods DOPPS is an international prospective and observational study. China participates in the DOPPS5 (2012～2015) and has completed the follow-up study of the cohort. A total of 1,427 HD patients included in the China DOPPS5. We recruited their pre-dialysis serum potassium and clinical data, and divided them into normal potassium group and hyperkalemia group (serum potassium ≥5.5mmol/L). Their demographic information, laboratory data and dialysis prescriptions were compared between the two groups. The independent risk factors for hyperkalemia were explored using multivariate logistic regression analysis. Results A total of 1,339 HD patients were enrolled in this study, with an average age of 59.4±14.9 years, 54.4% males, and an average dialysis vintage of 2.6 (0.9, 5.3) years. Hyperkalemia was detected in 345 patients (25.8%), of which 13.3% were mild hyperkalemia, 7.6% were moderate hyperkalemia, and 4.9% were severe hyperkalemia. Among the three cities involved in this study, the HD patients in Beijing had the highest rate of hyperkalemia (31.8%), followed by Guangzhou (26.0%) and Shanghai (19.3%) (χ2=18.580, P＜0.001). There were significant differences in age (t=2.610, P=0.009), gender (χ2=4.059, P=0.007), BMI (t=-2.680, P=0.008), dialysis adequacy (t=4.280, P＜0.001), dialysis frequency (χ2=21.548, P＜0.001), serum albumin (t=6.071, P＜0.001), and serum phosphorus (t=7.083, P＜0.001) between normal potassium group and hyperkalemia group. Multivariate logistic regression showed that higher
BMI (OR: 1.040, 95% CI: 1.004～1.077, P=0.027), female gender (OR:1.201, 95% CI: 1.023～2.547, P=0.026), potassium concentration in dialysate≥2.5mEq/L (compared to <2.5mEq/L) (OR: 1.194, 95% CI:1.028～1.386, P=0.020), lower dialysis adequacy (stdKt/V<2) (OR: 1.336, 95% CI: 1.170～1.527, P＜0.001), dialysis frequency＜3 times per week (OR: 1.332, 95% CI: 1.150～1.544, P＜0.001), higher serum albumin (OR: 1.815, 95% CI: 1.294～2.547, P＜0.001) and higher serum phosphorus (OR: 1.231, 95% CI: 1.153～1.316, P＜0.001) were the independent risk factors for hyperkalemia in HD patients (P＜0.05). Conclusion
The China DOPPS5 of hyperkalemia in HD patients found that hyperkalemia was detected in 25.8% HD patients. Among the three cities involved in this study, the HD patients in Beijing had the highest rate of hyperkalemia (31.8%), followed by Guangzhou (26.0%) and Shanghai (19.3%). Higher BMI, female gender, dialysate potassium concentration≥2.5mEq/L, stdKt/V＜2, dialysis frequency＜3 times per week, higher serum albumin and phosphorus levels were the independent risk factors for hyperkalemia in HD patients.
Key words
Hemodialysis /
Hyperkalemia /
DOPPS
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1]韦洮, 郑法雷.急性肾衰竭的钾代谢紊乱. 29(2):98-100.[J].北京医学., 2007; , :-
[2]左力, 赵新菊.终末期肾病患者应何时开始透析治疗. 肾脏病与透析肾移植杂志. 2018; 27(3):250-51.
[3]Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, et al.Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009 Aug; 24(8):2529-36.
[4]Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, et al.Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007 Sep; 2(5):999-1007.
[5]Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, et al.Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004 Jan; 19(1):100-7.
[6]Green D, Green HD, New DI, Kalra PA.The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease. Nephrol Dial Transplant. 2013 Jan; 28(1):99-105.
[7]Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, et al.Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2; 122(18 Suppl 3):S829-61.
[8]Truhlá? A, Deakin CD, Soar J, Khalifa GE, Alfonzo A, Bierens JJ, et al.European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitation. 2015 Oct; 95:148-201.
[9]Kunst G, Milojevic M, Boer C, De Somer F, Gudbjartsson T, van den Goor J, et al.2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019 Dec; 123(6):713-57.
[10]Kanbay M, Afsar B, Goldsmith D, Covic A.Sudden death in hemodialysis: an update. Blood Purif. 2010; 30(2):135-45.
[11]Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, et al.Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017 Feb; 69(2):266-77.
[12]Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, et al.Cardiac arrest and sudden death in dialysis units. Kidney Int. 2001 Jul; 60(1):350-7.
[13]Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP.Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int. 2011 Jan; 79(2):218-27.
[14]Basile C, Lomonte C.A neglected issue in dialysis practice: haemodialysate. Clin Kidney J. 2015 Aug; 8(4):393-9.
[15]Hung AM, Hakim RM.Dialysate and serum potassium in hemodialysis. Am J Kidney Dis. 2015 Jul; 66(1):125-32.
[16]Blumberg A, Roser HW, Zehnder C, Müller-Brand J.Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant. 1997 Aug; 12(8):1629-34.
[17]KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.Am J Kidney Dis. 2015 Nov; 66(5):884-930.
[18]Yan Y, Wang M, Zee J, Schaubel D, Tu C, Qian J, et al.Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study. Kidney Int Rep. 2018 Jul; 3(4):889-96.
[19]Bikbov B, Bieber B, Andrusev A, Tomilina N, Zemchenkov A, Zhao J, et al.Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS), with international comparisons. Hemodialysis international International Symposium on Home Hemodialysis. 2017 Jul; 21(3):393-408.
PDF(577 KB)
